Evidence map›Paper›PMID 23708370›Full record

ArticleBiophysical journal2013

A microscopic multiphase diffusion model of viable epidermis permeability.

Johannes M Nitsche, Gerald B Kasting

Abstract read
In one paragraph

Article in Biophysical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Establishment of anPeerJ · 2019
    Article
  4. Article
  5. Effect of stratum corneum heterogeneity, anisotropy, asymmetry and follicular pathway on transdermal penetration.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Johannes M NitscheDepartment of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY, USA. nitsche@buffalo.edu
Gerald B Kasting

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A microscopic model of passive transverse mass transport of small solutes in the viable epidermal layer of human skin is formulated on the basis of a hexagonal array of cells (i.e., keratinocytes) bounded by 4-nm-thick, anisotropic lipid bilayers and separated by 1-μm layers of extracellular fluid. Gap junctions and tight junctions with adjustable permeabilities are included to modulate the transport of solutes with low membrane permeabilities. Two keratinocyte aspect ratios are considered to represent basal and spinous cells (longer) and granular cells (more flattened). The diffusion problem is solved in a unit cell using a coordinate system conforming to the hexagonal cross section, and an efficient two-dimensional treatment is applied to describe transport in both the cell membranes and intercellular spaces, given their thinness. Results are presented in terms of an effective diffusion coefficient, D¯(epi), and partition coefficient, K¯(epi/w), for a homogenized representation of the microtransport problem. Representative calculations are carried out for three small solutes-water, L-glucose, and hydrocortisone-covering a wide range of membrane permeability. The effective transport parameters and their microscopic interpretation can be employed within the context of existing three-layer models of skin transport to provide more realistic estimates of the epidermal concentrations of topically applied solutes.

Indexed as

Cell Membrane PermeabilityFacilitated DiffusionModels, BiologicalCell MembraneEpidermal CellsEpidermisGlucoseHumansHydrocortisoneKeratinocytesGlucoseHydrocortisone

Identifiers

PMID23708370
PMCPMC3660641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.